Paydirt
MW
Insider

Mats Wahlstrom

Director

Mats Wahlstrom (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in TriSalus Life Sciences, Inc. (TLSI). Across 1 priced purchase filing, the average 21-session return was +69.4% from execution and +55.8% from disclosure (delay-adjusted; derived). The largest single filing was $152K of TLSI (60,000 sh × $2.53, as filed), executed May 15.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
+69.4%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+55.8%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$152K
shares × price, as filed
Last traded
May 15
Filed May 18
Open performance
Volume by month
$152K$76K$0Oct 2024Apr 2025Oct 2025Apr 2026May 2026 · buys $152K
Buys $152K Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
TLSI TriSalus Life Sciences, Inc. TLSI · 1 buy · 0 sells 1 filing
Recent filings
TLSIPURCHASE TriSalus Life Sciences, Inc. View filing → $152K
60,000 sh × $2.53
Exec May 15
Filed May 18 · 4:42 PM ET